453 Results

People

  1. Kelsen
    Kelsen
  2. Motzer
    Motzer
  3. Kris
    Kris
  4. Saltz
    Saltz
  5. Abrey
    Abrey
  6. O'Reilly
    O'Reilly
  7. Schwartz
    Schwartz
  8. Hudis
    Hudis
  9. Aghajanian
    Aghajanian
  10. De Angelis
    De Angelis

Groups

  1. Department of Medicine (312)
  2. Solid Tumor Oncology Division (250)
  3. Survivorship Research (79)
  4. Gastrointestinal Oncology Service (76)
  5. Hematologic Malignancies, Division of (76)
  6. Radiology, Department of (64)
  7. Center for Hematologic Malignancies (63)
  8. Epidemiology and Biostatistics (61)
  9. Biostatistics Service (60)
  10. Genitourinary Oncology Service (59)
  1. "leukopenia"
Formats
  1. Journal Article (435)
  2. Review (9)
  3. Conference Paper (4)
  4. Editorial (2)
  5. Research Letter (2)
  6. Miscellaneous (1)
Groups
  1. Department of Medicine (312)
  2. Solid Tumor Oncology Division (250)
  3. Survivorship Research (79)
  4. Gastrointestinal Oncology Service (76)
  5. Hematologic Malignancies, Division of (76)
  6. Radiology, Department of (64)

More Groups

People
  1. David Kelsen (33)
  2. Robert Motzer (29)
  3. Mark Kris (25)
  4. Leonard Saltz (21)
  5. Eileen O'Reilly (18)
  6. Lauren Abrey (18)

More People

Years
  1. 2025 (10)
  2. 2024 (26)
  3. 2023 (9)
  4. 2022 (8)
  5. 2021 (6)
  6. 2020 (15)

More Years

Publications
  1. Journal of Clinical Oncology (42)
  2. Cancer (33)
  3. Clinical Cancer Research (33)
  4. Annals of Oncology (15)
  5. Gynecologic Oncology (14)
  6. Investigational New Drugs (14)

More Publications

Publishers
  1. Elsevier Inc. (68)
  2. Springer (52)
  3. American Society of Clinical Oncology (43)
  4. Wiley Blackwell (39)
  5. American Association for Cancer Research (36)
  6. Oxford University Press (33)

More Publishers

Results (453)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: A pooled analysis
    Journal Article

    Antonia, S. J.; Borghaei, H.; Ramalingam, S. S.; Horn, L.; De Castro Carpeño, J.; Pluzanski, A.; Burgio, M. A.; Garassino, M.; Chow, L. Q. M.; Gettinger, S.; more...
    Lancet Oncology (2019)

    Fulltext@MSK | Save
  • Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: A phase 1 dose escalation/randomised phase 2a trial
    Journal Article

    Morris, M. J.; Loriot, Y.; Sweeney, C. J.; Fizazi, K.; Ryan, C. J.; Shevrin, D. H.; Antonarakis, E. S.; Pandit-Taskar, N.; Deandreis, D.; Jacene, H. A.; more...
    European Journal of Cancer (2019)

    Fulltext@MSK | Save
  • Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): A double-blind, randomised, placebo-controlled, phase 3 trial
    Journal Article

    Fuchs, C. S.; Shitara, K.; Di Bartolomeo, M.; Lonardi, S.; Al-Batran, S. E.; Van Cutsem, E.; Ilson, D. H.; Alsina, M.; Chau, I.; Lacy, J.; more...
    Lancet Oncology (2019)

    Fulltext@MSK | Save
  • A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study
    Journal Article

    Monk, B. J.; Kauderer, J. T.; Moxley, K. M.; Bonebrake, A. J.; Dewdney, S. B.; Secord, A. A.; Ueland, F. R.; Johnston, C. M.; Aghajanian, C.
    Gynecologic Oncology (2018)

    Fulltext@MSK | Save
  • Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): A randomised, double-blind, placebo-controlled, phase 3 trial
    Journal Article

    Shitara, K.; Doi, T.; Dvorkin, M.; Mansoor, W.; Arkenau, H. T.; Prokharau, A.; Alsina, M.; Ghidini, M.; Faustino, C.; Gorbunova, V.; more...
    Lancet Oncology (2018)

    Fulltext@MSK | Save
  • Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma
    Journal Article

    Bellmunt, J.; Lalani, A. K. A.; Jacobus, S.; Wankowicz, S. A.; Polacek, L.; Takeda, D. Y.; Harshman, L. C.; Wagle, N.; Moreno, I.; Lundgren, K.; more...
    British Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Autologous CD19-Targeted CAR T cells in patients with residual CLL following initial purine analog-based therapy
    Journal Article

    Geyer, M. B.; Rivière, I.; Sénéchal, B.; Wang, X.; Wang, Y.; Purdon, T. J.; Hsu, M.; Devlin, S. M.; Halton, E.; Lamanna, N.; more...
    Molecular Therapy (2018)

    Fulltext@MSK | Save
  • Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
    Journal Article

    Dang, N. H.; Ogura, M.; Castaigne, S.; Fayad, L. E.; Jerkeman, M.; Radford, J.; Pezzutto, A.; Bondarenko, I.; Stewart, D. A.; Shnaidman, M.; more...
    British Journal of Haematology (2018)

    Fulltext@MSK | Save
  • Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial
    Journal Article

    Guo, J.; Jin, J.; Oya, M.; Uemura, H.; Takahashi, S.; Tatsugami, K.; Rha, S. Y.; Lee, J. L.; Chung, J.; Lim, H. Y.; more...
    Journal of Hematology & Oncology (2018)

    Fulltext@MSK | Save
  • Long-term outcomes of adult medulloblastoma patients treated with radiotherapy
    Journal Article

    De, B.; Beal, K.; De Braganca, K. C.; Souweidane, M. M.; Dunkel, I. J.; Khakoo, Y.; Gilheeney, S. W.; DeAngelis, L. M.; Menzel, P.; Patel, S. H.; more...
    Journal of Neuro-Oncology (2018)

    Fulltext@MSK | Save